Addressing Alzheimer's

Fresh insights and tools are empowering start-ups pursuing treatments for Alzheimer's disease.

Alzheimer's disease is a ruthless disorder that steals people's memories, their ability to process information and eventually, even their personalities. Some 2% of people living in industrialized nations currently suffer from this neurodegenerative disorder, and the incidence is expected to triple within 50 years. In the US, some 4 million people presently have the disease. The severe toll it exacts—for people afflicted by it as well as their caregivers—makes Alzheimer's one of the most hotly pursued areas of neurological research.

A number of treatments have been approved for AD, all of which can help to improve an Alzheimer's patient's memory...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip